×

Methods for reducing CD36 expression

  • US 9,150,614 B2
  • Filed: 11/08/2013
  • Issued: 10/06/2015
  • Est. Priority Date: 09/16/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating diabetic retinopathy in a subject in need thereof comprising administering to the subject an effective amount of an aromatic-cationic peptide having the formula D-Arg-2′

  • 6′

    -Dmt-Lys-Phe-NH2 or Phe-D-Arg-Phe-Lys-NH2 or a pharmaceutically acceptable salt thereof.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×